General Cannabis (CANN) AI Stock Analysis

• Market Cap: $4.21M
• Dividend Yield: N/A
• Average Volume (3M): 152.58K
• Price to Earnings (P/E): ―
• Beta (1Y): -0.27
• Revenue Growth: N/A
• EPS Growth: N/A
• Country: US
• Employees: 91
• Sector: Healthcare
• Sector Strength: 45
• Industry: Drug Manufacturers - Specialty & Generic
• EPS (TTM): -0.01
• Shares Outstanding: 108,746,520
• 10 Day Avg. Volume: 152,002
• 30 Day Avg. Volume: 152,580
• PEG Ratio: 0.01
• Price to Book (P/B): -0.64
• Price to Sales (P/S): 0.14
• P/FCF Ratio: -2.78
• Enterprise Value/Market Cap: 4.53
• Enterprise Value/Revenue: 1.39
• Enterprise Value/Gross Profit: 3.28
• Enterprise Value/Ebitda: 22.42
• 1Y Price Target: N/A
• Price Target Upside: N/A
• Rating Consensus: Hold
• Number of Analyst Covering: 0
• EPS Forecast (FY): N/A
• Revenue Forecast (FY): N/A

• Rating: 45 Neutral
• Price Target: $0.05 ▲(12.50% Upside)

General Cannabis has significant financial challenges, with declining revenues and high leverage being the most critical issues. While the stock shows some technical strength, the overbought RSI suggests caution. The negative P/E ratio and lack of dividend yield further weigh down the overall score.

Positive Factors

Regulatory Environment

The anticipated reclassification of marijuana to a less regulated category could reduce operational barriers and enhance investment, benefiting General Cannabis' growth prospects in the evolving legal cannabis market.

Diverse Revenue Streams

General Cannabis' diverse revenue streams from consulting, real estate, and branding services provide a stable financial base and reduce dependency on any single market segment, supporting long-term business resilience.

Strategic Partnerships

Strategic partnerships with cannabis operators expand General Cannabis' market reach and create additional revenue opportunities, strengthening its competitive position and supporting sustainable growth.

Negative Factors

High Leverage

High leverage poses financial risk, limiting General Cannabis' ability to invest in growth opportunities and increasing vulnerability to economic downturns, impacting long-term financial stability.

Declining Revenue

Declining revenues and negative profit margins indicate operational inefficiencies, challenging General Cannabis' ability to maintain profitability and invest in future growth, affecting long-term viability.

Negative Cash Flow

Negative cash flows highlight liquidity challenges, constraining General Cannabis' capacity to fund operations and strategic initiatives, potentially hindering long-term growth and financial health.

General Cannabis Business Overview & Revenue Model

Company Description

Trees Corporation provides products and services to the regulated cannabis industry and non-cannabis customers in the United States. The company operates through Retail and Cultivation segments. It operates a licensed 17,000 square foot light deprivation greenhouse cultivation facility; and a retail dispensary store in Englewood, Colorado, as well as two retail stores in Portland, Oregon. The company was formerly known as General Cannabis Corp. and changed its name to Trees Corporation in June 2022. Trees Corporation was incorporated in 2013 and is headquartered in Denver, Colorado.

How the Company Makes Money

General Cannabis generates revenue through multiple channels. Its primary revenue streams include consulting services, where the company offers strategic guidance and operational support to cannabis businesses. Additionally, the company earns income from real estate services, leveraging its properties to cater to cannabis operations. The sale of cannabis-related products and branding services also contributes to its revenue. Strategic partnerships with various cannabis operators enhance its market presence and create additional revenue opportunities, while the overall growth in the legal cannabis market adds to its financial performance.

General Cannabis Financial Statement Overview

Summary

General Cannabis faces significant financial challenges, with declining revenues, high leverage, and negative profitability. The company needs to address operational inefficiencies and improve its financial stability to enhance its financial health.

Income Statement

General Cannabis has shown declining revenue growth with a negative trend in net profit margins, indicating challenges in profitability. The gross profit margin is moderate, but the EBIT and EBITDA margins are negative, reflecting operational inefficiencies.

Balance Sheet

The company has a high debt-to-equity ratio, indicating significant leverage, which poses financial risk. Negative stockholders' equity and poor return on equity further highlight financial instability.

Cash Flow

Operating and free cash flows are negative, although there is some improvement in free cash flow growth. The ratios of cash flow to net income suggest cash flow challenges relative to earnings.

Breakdown	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020
Income Statement
Total Revenue	13.66M	18.14M	13.44M	5.93M	7.12M
Gross Profit	5.45M	6.57M	4.87M	1.49M	1.65M
EBITDA	900.75K	-1.64M	-2.84M	-6.12M	-6.19M
Net Income	-3.48M	-7.08M	-9.48M	-8.87M	-7.68M
Balance Sheet
Total Assets	20.76M	23.25M	31.69M	22.02M	8.52M
Cash, Cash Equivalents and Short-Term Investments	214.33K	969.68K	2.58M	2.05M	750.22K
Total Debt	17.31M	17.88M	22.54M	10.15M	4.76M
Total Liabilities	23.84M	23.10M	25.29M	12.42M	7.52M
Stockholders Equity	-3.07M	148.16K	6.41M	9.61M	1.00M
Cash Flow
Free Cash Flow	-704.76K	-1.43M	-2.11M	-2.98M	-5.32M
Operating Cash Flow	-654.15K	-1.13M	-2.05M	-2.65M	-5.00M
Investing Cash Flow	-50.60K	-304.42K	-1.95M	-978.74K	1.11M
Financing Cash Flow	-50.59K	-184.25K	4.53M	4.93M	4.42M

General Cannabis Technical Analysis

• Technical Analysis Sentiment: Negative
• Last Price: 0.04
• 50DMA: Negative
• 100DMA: Negative
• 200DMA: Positive
• MACD: Positive
• RSI: Neutral
• STOCH: Neutral

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For CANN, the sentiment is Negative. The current price of 0.04 is below the 20-day moving average (MA) of 0.04, below the 50-day MA of 0.04, and above the 200-day MA of 0.04, indicating a neutral trend. The MACD of <0.01 indicates Positive momentum. The RSI at 43.37 is Neutral, neither overbought nor oversold. The STOCH value of 40.00 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for CANN.

General Cannabis Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
AQST	56 Neutral	$727.14M	-8.35	―	―	-26.32%	-56.54%
Sector *	51 Neutral	$7.86B	-0.30	-43.30%	2.27%	22.53%	-2.21%
FLGC	46 Neutral	$5.64M	-0.22	-37.38%	―	-22.60%	53.82%
IMCC	45 Neutral	$7.92M	-1.87	-93.87%	―	-0.74%	81.49%
CANN	45 Neutral	$4.21M	-1.18	―	―	―	―
YCBD	40 Underperform	$12.22M	-0.42	-44.42%	―	-1.50%	80.17%
IXHL	39 Underperform	$153.27M	-0.37	-114.52%	―	-86.05%	24.17%

General Cannabis Corporate Events

General Cannabis Completes Acquisition of Beddor Claude LLC

General Cannabis, through its subsidiary Trees Colorado LLC, completed the acquisition of Beddor Claude LLC, a cannabis dispensary and cultivation operation in Wheat Ridge, Colorado, on June 30, 2025. The acquisition involved a payment of $1,704,827.87 and a new lease agreement with favorable terms. Earlier, on June 20, 2025, the company entered into a restructuring arrangement with TCM Tactical Opportunities Fund II LP and other debt holders, resulting in a new refinancing agreement and the issuance of senior promissory notes. This restructuring aims to strengthen the company’s financial position and includes enhanced covenants and a new consulting agreement with its interim CEO, Adam Hershey.